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Abstract 
In the translation of psychoneuroimmunology research into clinical practice, one critical step 
is to identify biomarkers for improved diagnosis and targeting of interventions. Inflammatory 
markers deserve special attention due to their crucial role linking various health conditions 
and disorders. In this chapter, authors discuss the pivotal roles of cytokines in signalling to 
the brain and leading to behavioural changes. This is followed by a review of recent research 
findings into neuroimmunology of depression, and immunomodulating effects of 
antidepressants. The rest of the chapter focuses on neuroinflammatory hypothesis in anxiety 
disorders, and provides an overview of current research evidence on inflammatory responses 
in anxious state and anxiety disorders. Research suggestions are recommended, including 
study design, risk factors, medication effects, and measurement  strategies. Clinical and 
pharmacotherapeutic implications and future research directions are also discussed in the 
final section.  
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